About CannBerry Tek

CannBerryTek, Inc. holds 100% of CannBerryTek Ltd. CannBerryTek Ltd. – a Hi-tech innovative Biotechnology Company will manage various Research & Development (“R & D”) activities with the major focus on the Medical Cannabis industry.

CannBerryTek Ltd. (“CannBerry”) has assembled a powerful highly experienced R&D management team to operate in Israel. During the initial phase, CannBerryTek Ltd. intends to focus on generating and developing a unique man-made repository of seeds known as a Cannabis Genetic Seed Bank to create and secure rare, hard-to-find or difficult to legally obtain Cannabis seed types and varieties.

In that regard, CannBerryTek Ltd. intends to apply unique proprietary technological tools developed by its management to monitor Cannabis under sterile conditions in a fully controlled environment. During the second phase, CannBerryTek Ltd. intends to form unique Active Pharmaceutical Ingredient formulations to develop specific Cannabis-based products for the Medical Cannabis industry. An Active Pharmaceutical Ingredient is any substance or mixture of substances intended to be used in the manufacture of a drug (medicinal) product and that, when used in the production of a drug, becomes an active ingredient of the drug product. Such substances are intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or function of the body. CannBerryTek Ltd.’s mission is to become a leading supplier of superior genetics as well as Active Pharmaceutical Ingredients to the Cannabis industry.

CannBerryTek Ltd. is under advanced discussions with Shiva Medical Care Center ( among the top 10 worldwide  Medical Center)  to establish joint venture in implementing Cannabis products to fight most aggressive cancers

In order to reinforce its Product varieties and R & D capabilities, CannBerry intends to leverage its close relationships with leading Cannabis Research Centers including but not limited to the Agricultural Research Organization – Volcani Center (http://www.moag.gov.il/en/About%20the%20Ministry/ministry_sites/Pages/agricultural_research_organization.aspx), Weizmann Institute of Science (https://www.weizmann.ac.il/pages/), Hebrew University Agriculture Faculty (https://en.hafakulta.agri.huji.ac.il/) and Technion’s Faculty of Medicine – Bruce Rappaport Faculty of Medicine (https://md.technion.ac.il/about/) and Tel Aviv University Agricultural Research Center to establish R & D Joint Ventures.

Also under progress discussions with

Potential sources of income from the development of proprietary strains are (1) licensing of premium genetic strains (2) wholesale seed sales (3) clone fulfillment services (4) custom breeding programs and (5) tissue culture and strain patenting services.

CannBerryTek – Company Overview